carbamates has been researched along with Agyria in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toba, S | 1 |
| Tamura, Y | 1 |
| Kumamoto, K | 1 |
| Yamada, M | 1 |
| Takao, K | 1 |
| Hattori, S | 1 |
| Miyakawa, T | 1 |
| Kataoka, Y | 1 |
| Azuma, M | 1 |
| Hayasaka, K | 1 |
| Amamoto, M | 1 |
| Tominaga, K | 1 |
| Wynshaw-Boris, A | 1 |
| Wanibuchi, H | 1 |
| Oka, Y | 1 |
| Sato, M | 1 |
| Kato, M | 1 |
| Hirotsune, S | 1 |
1 other study available for carbamates and Agyria
| Article | Year |
|---|---|
Post-natal treatment by a blood-brain-barrier permeable calpain inhibitor, SNJ1945 rescued defective function in lissencephaly.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Administration, Oral; Animals; Blood-Brain Barrier; | 2013 |